Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (27)

2023

  1. Clinical description, molecular delineation and genotype-phenotype correlation in 340 patients with KBG syndrome: Addition of 67 new patients

    Journal of Medical Genetics, Vol. 60, Núm. 7, pp. 644-654

2022

  1. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

  2. Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group

    Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 446-459

2021

  1. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

2020

  1. Intensity normalization methods in brain FDG-PET quantification

    NeuroImage, Vol. 222

2018

  1. Optimization of the reconstruction parameters in [123I]FP-CIT SPECT

    Physics in Medicine and Biology, Vol. 63, Núm. 8

2017

  1. Radiation therapy in extensive stage small cell lung cancer

    Frontiers in Oncology, Vol. 7, Núm. AUG

2016

  1. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]

    Reports of Practical Oncology and Radiotherapy

  2. Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Clinical and Translational Oncology, Vol. 18, Núm. 4, pp. 331-341

  3. GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases

    Annals of Oncology, Vol. 27, pp. vi383

  4. No role for trimodality therapy and consolidation chemotherapy compared with concurrent radiochemotherapy alone in stage III non-small-cell lung cancer

    Journal of Clinical Oncology

2015

  1. Frequency and characteristics of familial melanoma in Spain: The FAM-GEM-1 study

    PLoS ONE, Vol. 10, Núm. 4

  2. Imaging of Tumor Angiogenesis for Radiologists-Part 1: Biological and Technical Basis

    Current Problems in Diagnostic Radiology, Vol. 44, Núm. 5, pp. 407-424

  3. Imaging of Tumor Angiogenesis for Radiologists-Part 2: Clinical Utility

    Current Problems in Diagnostic Radiology, Vol. 44, Núm. 5, pp. 425-436

  4. Monte Carlo simulations versus experimental measurements in a small animal PET system. A comparison in the NEMA NU 4-2008 framework

    Physics in Medicine and Biology, Vol. 60, Núm. 1, pp. 151-162

  5. The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy

    Journal of Urology, Vol. 193, Núm. 6, pp. 1963-1969

  6. Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance

    Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 4, pp. 259-272

2014

  1. Analytical, experimental, and Monte Carlo system response matrix for pinhole SPECT reconstruction

    Medical Physics, Vol. 41, Núm. 3

  2. The performance of a hybrid analytical-Monte Carlo system response matrix in pinhole SPECT reconstruction

    Physics in Medicine and Biology, Vol. 59, Núm. 24, pp. 7573-7585

2013

  1. Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

    British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572